Patent application number | Description | Published |
20090099179 | COMPOUNDS FOR DISEASES AND DISORDERS - The invention provides novel compounds useful for the treatment of disorders associated with a defect in vesicular transport (e.g., axonal transport). The compounds have a substituents chosen from -L-C(═O)OH, -L-CH═CHC(═O)OH, -L-C(═O)NH | 04-16-2009 |
20090253768 | THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS - Pyrrole derivatives are disclosed as agents for the treatment and prevention of neuropathies and neurodegenerative diseases characterized by the presence of axonal blockages, impaired axonal transport or impaired trafficking of vesicles in neurons. | 10-08-2009 |
20120065241 | THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS - Pyrrole derivatives are disclosed as agents for the treatment and prevention of neuropathies and neurodegenerative diseases characterized by the presence of axonal blockages, impaired axonal transport or impaired trafficking of vesicles in neurons. | 03-15-2012 |
20120225845 | COMPOUNDS FOR DISEASES AND DISORDERS - The invention provides novel compounds useful for the treatment of disorders associated with a defect in vesicular transport (e.g., axonal transport). The compounds have a substituents chosen from -L-C(═O)OH, -L-CH═CHC(═O)OH, -L-C(═O)NH | 09-06-2012 |
20130261118 | COMPOUNDS FOR ALZHEIMER'S DISEASE - The present disclosure relates to novel indole and tetrahydroindole core compounds useful for the treatment of disorders associated with a defect in vesicular transport (e.g., axonal transport). | 10-03-2013 |
Patent application number | Description | Published |
20100035971 | Methods and Means Related to Diseases - The present invention relates to the fields of genetics and oncology and provides methods for detecting cutaneous T-cell lymphomas (CTCL) or susceptibility to CTCL. Specifically, the present invention relates to a novel method for the diagnosis and follow-up of CTCL or CTCL subtype, the method comprising determination of expression of one or more genes, gene fragments or gene products. The present invention further relates to a novel method of detecting the response to CTCL therapy, the method comprising determining expression of one or more genes or gene fragments or gene products in a biological sample. The present invention further relates to a novel method of developing or improving CTCL therapy or developing anti-CTCL medicament, the method comprising screening agents affecting one or several of the genes or gene products. The present invention further relates to a novel method of treating CTCL patients, the method comprising affecting one or several of the genes or gene products. The present invention further relates to a novel test kit, the kit comprising the necessary means for detecting one or more genes, gene fragments or gene products. The present invention also relates to a use of one or more genes, gene fragments or gene products for determination, diagnosis or follow-up of CTCL or CTCL subtype and for detection of the response to CTCL therapy. The present invention also relates to a use of one or more target molecules for CTCL therapy or for the preparation of a medicament for treating CTCL. | 02-11-2010 |
20130029337 | METHODS AND USES INVOLVING GENETIC ABNORMALITIES AT CHROMOSOME 12 - The present invention relates to the fields of genetics and oncology and provides methods for predicting and identifying tumors of epithelial origin. Specifically, the present invention relates to a novel method of predicting tumor initiation, tumor progression and/or carcinomas, the method comprising detecting genetic abnormality associated with tumors of epithelial origin. The present invention further relates to a novel method of identifying an individual with potential for developing carcinoma, the method comprising detection of genetic abnormalities. The present invention also relates to a method of predicting the progression of carcinomas and the transformation thereof to an aggressive variant, the method comprising detection of genetic abnormalities, which indicate the probability to develop carcinoma. The present invention also relates to a use of specific chromosomal region, a gene or a fragment thereof, and/or genetic markers for predicting tumor initiation, tumor progression and/or carcinoma. The present invention also relates to a use of specific chromosomal region or a gene or a fragment thereof in therapy, for the development of therapy, and for the preparation of a medicament for treating tumors of epithelial origin. | 01-31-2013 |
Patent application number | Description | Published |
20110015459 | Process for the preparation of light fuels - In the process of the invention, an aliphatic C | 01-20-2011 |
20130199481 | GASOLINE COMPOSITIONS AND METHOD OF PRODUCING THE SAME - Gasoline fuel and method of making and using it. The fuel comprises from 5 to 20 vol.-% paraffinic hydrocarbons originating from biological oils, fats, or derivatives or combinations thereof. Further, it comprises oxygenates, such as ethanol present in a concentration of about 5 to 15 vol.-%; or iso-butanol present in a concentration of 5 to 20 vol.-%, preferably about 10 to 17 vol.-%; or ETBE present in a concentration of 7 to 25 vol.-%, preferably about 15 to 22 vol.-%. The bioenergy content of the gasoline is at least 14 Energy equivalent percentage (E | 08-08-2013 |
20150144087 | GASOLINE COMPOSITIONS AND METHOD OF PRODUCING THE SAME - Gasoline fuel and method of making and using it. The fuel comprises from 5 to 20 vol.-% paraffinic hydrocarbons originating from biological oils, fats, or derivatives or combinations thereof. Further, it comprises oxygenates, such as ethanol present in a concentration of about 5 to 15 vol.-%; or iso-butanol present in a concentration of 5 to 20 vol.-%, preferably about 10 to 17 vol.-%; or ETBE present in a concentration of 7 to 25 vol.-%, preferably about 15 to 22 vol.-%. The bioenergy content of the gasoline is at least 14 Energy equivalent percentage (E | 05-28-2015 |
Patent application number | Description | Published |
20140145361 | METHOD AND APPARATUS FOR CASTING CONCRETE PRODUCTS - A method and an apparatus for casting concrete products with a substantially horizontal slipform casting process, where concrete mass is fed through a restricted cross-section defining the product to be cast, and which restricted cross-section moves progressively along with the casting process in relation to a casting bed, wherein the height of the cast product exiting the restricted cross-section is measured during the casting process, and the height and/or position of the leveling plate of the upper surface of the restricted cross-section is adjusted during the casting process based on the height measurement of the cast product. | 05-29-2014 |
20140165986 | APPARATUS FOR SAWING CURED SLIPFORM CAST CONCRETE PRODUCTS - An apparatus for sawing cured slipform cast concrete products, which apparatus comprises a frame with wheels, and a concrete saw connected movably to the frame, wherein the apparatus comprises a brushing unit for cleaning slipform casting bed. | 06-19-2014 |
20150086321 | METHOD FOR LIFTING A CONCRETE PRODUCT WITH A LIFTING BOOM AND LIFTING BOOM - Method for lifting a concrete product with a lifting boom and a lifting boom, in which method the lifting boom is moved above the concrete product to be lifted with a crane, lifting hooks of the lifting boom are set in lifting loops located in the concrete product to be lifted, and the lifting is carried out by lifting the lifting boom together with the concrete product with a crane, wherein the location of at least one lifting loop in the concrete product to be lifted is detected by a control system of the lifting boom, which control systems moves at least one lifting hook along the lifting boom to the location of the lifting loop. | 03-26-2015 |
Patent application number | Description | Published |
20120035311 | COLORED BUBBLES - A colored bubble composition for producing colored bubbles having water, at least one humectant, at least one water soluble polymer, and at least one colorant. The colored bubble composition may be obtained by mixing water, at least one humectant, and at least one water soluble polymer to form a mixture, wherein the mixture does not comprise a colorant. Subsequently, at least one colorant is added to the mixture. In particular, a mixture of water, at least one humectant, and at least one water soluble polymer may be heated to a temperature in the range of about 40 to 60° C. and subsequently, cooled to about 20 to 30° C. The at least one colorant is then added to the cooled mixture. | 02-09-2012 |
20130267146 | MOLDABLE SAND COMPOSITIONS AND METHODS FOR MAKING THE SAME - The present invention relates to moldable sand compositions, methods for making the moldable sand compositions, and methods for using the moldable sand compositions. In a particular embodiment, the moldable sand composition comprises between about 70% to about 95% sand, between about 5% to about 30% water, a polar polymeric resin, a crosslinking agent, and a humectant. In an exemplary embodiment, the composition contains no oils, waxes, glycols, or rubbers. The composition is capable of becoming hardened over time in order to maintain the achieved shape, and can be re-wetted and molded again after becoming hardened. | 10-10-2013 |
20140099863 | MOLDABLE SAND COMPOSITIONS AND METHODS FOR MAKING THE SAME - The present invention relates to moldable sand compositions, methods for making the moldable sand compositions, and methods for using the moldable sand compositions. In a particular embodiment, the moldable sand composition comprises between about 70% to about 95% sand, between about 5% to about 30% water, a polar polymeric resin, a crosslinking agent, and a humectant. In an exemplary embodiment, the composition contains no oils, waxes, glycols, or rubbers. The composition is capable of becoming hardened over time in order to maintain the achieved shape, and can be re-wetted and molded again after becoming hardened. | 04-10-2014 |
20150175810 | DISSOLVABLE FILMS AND METHODS OF USING THE SAME - The present invention provides dissolvable films for customizing art materials, such as inks, paints, and modeling doughs. The invention also provides methods and kits for delivering artistic effects to art materials. The dissolvable films comprise one or more cellulose compounds, propylene glycol, glycerin, and one or more artistic components. The dissolvable film imparts an artistic effect following administration of the film to the art material. In exemplary embodiments, the artistic components of the film comprise one or more colorants which provide a coloring effect. A kit for delivering one or more artistic effects to an art material includes dissolvable films of various colors and shapes, and one or more art materials, such as ink, paint, or modeling dough. | 06-25-2015 |
20150225534 | MOLDABLE SAND COMPOSITIONS AND METHODS FOR MAKING THE SAME - The present invention relates to moldable sand compositions, methods for making the moldable sand compositions, and methods for using the moldable sand compositions. In a particular embodiment, the moldable sand composition comprises between about 70% to about 95% sand, between about 5% to about 30% water, a polar polymeric resin, a crosslinking agent, and a humectant. In an exemplary embodiment, the composition contains no oils, waxes, glycols, or rubbers. The composition is capable of becoming hardened over time in order to maintain the achieved shape, and can be re-wetted and molded again after becoming hardened. | 08-13-2015 |
Patent application number | Description | Published |
20100028913 | NOVEL CARBOHYDRATE FROM HUMAN CELLS AND METHODS FOR ANALYSIS AND MODIFICATION THEREOF - The invention describes reagents and methods for specific binders to glycan structures of stem cells. Furthermore the invention is directed to screening of additional binding reagents against specific glycan epitopes on the surfaces of the stem cells. The preferred binders of the glycans structures includes proteins such as enzymes, lectins and antibodies. | 02-04-2010 |
20100047827 | NOVEL SPECIFIC CELL BINDERS - The invention describes reagents and methods for specific binders to glycan structures of stem cells. Furthermore the invention is directed to screening of additional binding reagents against specific glycan epitopes on the surfaces of the stem cells. The preferred binders of the glycans structures includes proteins such as enzymes, lectins and antibodies. | 02-25-2010 |
20100068806 | NOVEL METHODS AND REAGENTS DIRECTED TO PRODUCTION OF CELLS - The present invention provides methods and materials to modulate and grow stem cells by contacting stem cells with a binder recognizing terminal glycan structures of stem cells. The modulation can be morphological change, change in differentiation status, biological status or adherence. The materials provided in the present invention are also useful to screen such a binding agents and binders. | 03-18-2010 |
20100145032 | NOVEL CARBOHYDRATE PROFILE COMPOSITIONS FROM HUMAN CELLS AND METHODS FOR ANALYSIS AND MODIFICATION THEREOF - The invention describes reagents and methods for specific binders to glycan structures of stem cells. Furthermore the invention is directed to screening of additional binding reagents against specific glycan epitopes on the surfaces of the stem cells. The preferred binders of the glycans structures includes proteins such as enzymes, lectins and antibodies. | 06-10-2010 |
20100292095 | HUMAN MONOCLONAL ANTIBODIES DIRECTED TO SIALYL LEWIS C, SIALYL TN AND N GLYCOLYLNEURAMINIC ACID EPITOPES AND A METHOD OF ANALYSIS OF STEM CELLS COMPRISING SAID EPITOPES - This invention relates to antibody engineering technology. More particularly, the present invention relates to human IgM antibodies and derivatives thereof, which have novel binding specificity with regard to several oligosaccharide sequences and/or xenoantigenic sialic acid residue. The present invention also relates to processes for making and engineering such novel saccharide and/or NeuGc-binding monoclonal antibodies and to methods for using these antibodies and derivatives thereof in the field of immunodiagnostics, enabling qualitative and quantitative determination of xenoantigenic NeuGc in biological and raw material samples, as well as in immunotherapy, enabling blocking of xenoantigenic NeuGc in patients. | 11-18-2010 |
20110045497 | NOVEL ACIDIC GLYCAN MARKERS OF HUMAN CELLS - The invention is directed to the analysis of novel acidic glycan markers of several types of human cells. The analysis is performed by mass spectrometry or specific binder molecules. | 02-24-2011 |
20110136203 | ENZYMATICAL MODIF ICATION OF CELL GLYCOSYLATION USING SERUM ALBUMIN AND DIVALENT CATIONS - The invention is directed to a method and kit to control and modify the status of cells, such as human stem cells, by changing their glycosylation, in particular sialylation and fucosylation, levels in a reaction condition where culture medium reagents, such as divalent cations, are present and cells are kept non-adherent. The invention is further directed to novel stem cells, the glycosylation of which has been specifically altered. | 06-09-2011 |
20110143373 | METHOD OF EVALUATING THE INTEGRITY OF THE PLASMA MEMBRANE OF CELLS BY DETECTING GLYCANS FOUND ONLY INTRACELLULARLY - The invention describes novel reagents that can be applied for analysis of the quality of human cells. The method evaluates the integrity of the plasma membrane of the cells by detecting novel glyco structures found only intracellularly. The method can be applied, for example, to demonstrate exposure of therapeutic cell preparation to potentially harmful conditions. It can also be used as a quality control tool in methods in which intact cell membrane is essential and it can be applied in separation of damaged cells from non- damaged. | 06-16-2011 |
20120129712 | ANTIBODIES DIRECTED TO TRA ANTIGENS, AND METHODS OF PRODUCTION, SCREENING AND ANALYSIS OF SAID ANTIBODIES, AS WELL AS METHODS OF ANALYSIS OF STEM CELLS AND CANCER CELL - A complex of Tra-antibody bound to an isolated glycan comprising type I—N-acetyllactosamine comprising target structure, and methods and uses utilizing said complex. | 05-24-2012 |
20130034901 | Use of a Proteolytic Enzyme for the Modification of the Cell Surface of a Stem Cell - The present invention relates to a stem cell and/or a population thereof having a specific profile of cell surface proteins and/or proteoglycans. The present invention also relates to use of a proteolytic enzyme in the modification of the cell surface of a stem cell. The present invention further relates to a method of modifying the cell surface of a stem cell by treatment with a proteolytic enzyme. | 02-07-2013 |
Patent application number | Description | Published |
20080248016 | Novel Iaccase Enzymes and Their Uses - The present invention relates to novel laccase enzymes obtainable from the strains of the genus | 10-09-2008 |
20100204080 | Novel Cellulases and Their Uses - The present invention provides novel cellulase fusion proteins, preparations of cellulase fusion proteins and compositions of cellulase fusion proteins. The present invention further provides cellulase expression vectors, host cells expressing cellulase and methods for preparing such vectors and cells. Uses of cellulases, cellulase preparations and cellulase compositions in the textile, detergent, pulp and paper industries are also provided. | 08-12-2010 |
20110003729 | Novel fungal protease and use thereof - The present invention is related to a fungal serine protease enzyme, which comprises an amino acid sequence of the mature Fe_RF6318 enzyme having an amino acid sequence of SEQ ID NO: 15. The serine protease is obtainable from | 01-06-2011 |
20110008870 | Fungal protease and use thereof - The present invention is related to a fungal serine protease enzyme useful in modification, degradation or removal of proteinaceous material, which enzyme comprises an amino acid sequence of the mature Tr Prb1 enzyme having an amino acid sequence of SEQ ID NO: 10 or a variant thereof having similar activity. The serine protease is obtainable from | 01-13-2011 |
20110028375 | Fungal serine protease and use thereof - The present invention is related to a fungal serine protease enzyme, which comprises an amino acid sequence the mature Fa_RF7182 enzyme having an amino acid sequence of SEQ ID NO: 18. The serine protease is obtainable from | 02-03-2011 |
20110269213 | Fungal Endoglucanases, Their Production and Use - Novel fungal endoglucanases Cel5 and Cel2 are disclosed. The endoglucanases are conveniently produced by recombinant technology, and means for their production are described. The endoglucanases are used for treating cellulosic material, especially in textile industry, e.g. in biofinishing or biostoning. They may also be used in detergents, in animal feed and/or in pulp and paper industry, or in hydrolysis of lignocellulosic material for, e.g. bioethanol production. | 11-03-2011 |
20120107905 | Variants of Fungal Serine Protease - The present invention relates to fungal serine protease variants, which comprise an amino acid substitution of valine at position 208 of the parent | 05-03-2012 |
20120252064 | Protease Enzyme and Uses Thereof - The present invention is related to a fungal serine protease enzyme, which said enzyme has serine protease activity and comprises an amino acid sequence of | 10-04-2012 |
20130065810 | Novel Fungal Protease and Use Thereof - The present invention is related to a fungal serine protease enzyme, which comprises an amino acid sequence of the mature Fe_RF6318 enzyme having an amino acid sequence of SEQ ID NO: 15. The serine protease is obtainable from | 03-14-2013 |
20140099678 | Fungal Endoglucanases, Their Production and Use - Novel fungal endoglucanases Cel5 and Cel12 are disclosed. The endoglucanases are conveniently produced by recombinant technology, and means for their production are described. The endoglucanases are used for treating cellulosic material, especially in textile industry, e.g. in biofinishing or biostoning. They may also be used in detergents, in animal feed and/or in pulp and paper industry, or in hydrolysis of lignocellulosic material for, e.g. bioethanol production. | 04-10-2014 |
20140134706 | Nucleic Acids Encoding Fungal Protease - The present invention is related to a fungal serine protease enzyme, which comprises an amino acid sequence of the mature Fe_RF6318 enzyme having an amino acid sequence of SEQ ID NO: 15. The serine protease is obtainable from | 05-15-2014 |
20140134707 | Nucleic Acids Encoding Fungal Serine Protease - The present invention is related to a fungal serine protease enzyme, which comprises an amino acid sequence the mature Fa_RF7182 enzyme having an amino acid sequence of SEQ ID NO: 18. The serine protease is obtainable from | 05-15-2014 |